ARCHIVES

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

Funding Opportunities listed.

December 5, 2003

New Report On Survival Data Available From NCI

July 25, 1975

In Brief: Thomas Jefferson Univ. Wins $5 Mil. P01; Former NCI Administrator Sentenced

November 6, 1992

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

Human Genome Consortium Completes “Working Draft”.

June 30, 2000